A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection
Open Access
- 11 February 2013
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1), 80
- https://doi.org/10.1186/1471-2334-13-80
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Hospital-Acquired Infections Due to Gram-Negative BacteriaNew England Journal of Medicine, 2010
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and OutcomesClinical Infectious Diseases, 2010
- Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniaeInfection Control & Hospital Epidemiology, 2009
- Extended-spectrum β-lactamase-producing organismsJournal of Hospital Infection, 2009
- Diversity of β-Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in BrazilAntimicrobial Agents and Chemotherapy, 2009
- Early Dissemination of KPC-2-Producing Klebsiella pneumoniae Strains in BrazilAntimicrobial Agents and Chemotherapy, 2009
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoEAntimicrobial Agents and Chemotherapy, 2006
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- APACHE IICritical Care Medicine, 1985